Jericho Assisted Living
Thursday, January 19, 2017
No Survival Advantage with ACE Inhibitors in Stable CAD (CME/CE)
(MedPage Today) -- Blocking RAS pathway not better than other preventive strategies
via
No Survival Advantage with ACE Inhibitors in Stable CAD (CME/CE)
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment